Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

News Conference News AHA 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

Todd Neale

November 11, 2018

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Michael O'Riordan

November 16, 2017

News Conference News AHA 2016

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Michael O'Riordan

November 16, 2016

News Conference News AHA 2015

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

Yael L. Maxwell

November 09, 2015

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

Presentation AHA 2012

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Presenter: Jay H. Traverse

November 05, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

Advertisement

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Cell Therapy Trials Show Mixed Results at AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

No LateTIME Benefit for Cell Therapy After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content